Pages that link to "Q40730152"
Jump to navigation
Jump to search
The following pages link to CD39 and control of cellular immune responses (Q40730152):
Displaying 50 items.
- The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism (Q24629291) (← links)
- Clinical lung xenotransplantation--what donor genetic modifications may be necessary? (Q26823663) (← links)
- The CD39-adenosinergic axis in the pathogenesis of immune and nonimmune diabetes (Q26825668) (← links)
- Regulatory T cells: Mechanisms of suppression and impairment in autoimmune liver disease (Q26827787) (← links)
- Th17 Cell Plasticity and Functions in Cancer Immunity (Q27012901) (← links)
- Mechanisms of chemical-induced innate immunity in allergic contact dermatitis (Q27687785) (← links)
- Regulatory T-Cells at the Interface between Human Host and Pathogens in Infectious Diseases and Vaccination (Q28081492) (← links)
- Streptococcus pneumoniae serotype 1 capsular polysaccharide induces CD8CD28 regulatory T lymphocytes by TCR crosslinking (Q33506614) (← links)
- CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression (Q33533705) (← links)
- CD39-mediated effect of human bone marrow-derived mesenchymal stem cells on the human Th17 cell function (Q33692614) (← links)
- Functional Proteomic Analysis for Regulatory T Cell Surveillance of the HIV-1-Infected Macrophage (Q33721196) (← links)
- Depletion of tumor-induced Treg prior to reconstitution rescues enhanced priming of tumor-specific, therapeutic effector T cells in lymphopenic hosts (Q33772479) (← links)
- Phenotypes and distribution of mucosal memory B-cell populations in the SIV/SHIV rhesus macaque model (Q33862010) (← links)
- Cystic fibrosis remodels the regulation of purinergic signaling by NTPDase1 (CD39) and NTPDase3 (Q33916983) (← links)
- High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population (Q33931235) (← links)
- CD39/adenosine pathway is involved in AIDS progression (Q33959186) (← links)
- Cellular function and molecular structure of ecto-nucleotidases. (Q34031794) (← links)
- Differential macrophage activation alters the expression profile of NTPDase and ecto-5'-nucleotidase (Q34163423) (← links)
- CD39 and CD161 modulate Th17 responses in Crohn's disease (Q34218735) (← links)
- Expression of CD39 on FoxP3+ T regulatory cells correlates with progression of HBV infection. (Q34226860) (← links)
- Extracellular nucleotides inhibit insulin receptor signaling, stimulate autophagy and control lipoprotein secretion (Q34271095) (← links)
- Regulatory T cells negatively affect IL-2 production of effector T cells through CD39/adenosine pathway in HIV infection (Q34711777) (← links)
- The GDA1_CD39 superfamily: NTPDases with diverse functions (Q34868468) (← links)
- Active immunization using a single dose immunotherapeutic abates established EAE via IL-10 and regulatory T cells (Q35134310) (← links)
- Liver damage and systemic inflammatory responses are exacerbated by the genetic deletion of CD39 in total hepatic ischemia (Q35574518) (← links)
- Autoimmune Hepatitis: Clinical Review with Insights into the Purinergic Mechanism of Disease (Q35906055) (← links)
- The Therapeutic Potential of Adenosine Triphosphate as an Immune Modulator in the Treatment of HIV/AIDS: A Combination Approach with HAART (Q35932071) (← links)
- P2X7 Receptor Inhibition Improves CD34 T-Cell Differentiation in HIV-Infected Immunological Nonresponders on c-ART (Q35991216) (← links)
- FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas (Q36009621) (← links)
- Gut microbiota, metabolites and host immunity (Q36031926) (← links)
- Fructose 1,6-bisphosphate, a high-energy intermediate of glycolysis, attenuates experimental arthritis by activating anti-inflammatory adenosinergic pathway (Q36174658) (← links)
- Expression of PD-1 Molecule on Regulatory T Lymphocytes in Patients with Insulin-Dependent Diabetes Mellitus. (Q36184263) (← links)
- Lysophosphatidic acid generation by pulmonary NKT cell ENPP-2/autotaxin exacerbates hyperoxic lung injury (Q36289438) (← links)
- NADH oxidase-dependent CD39 expression by CD8(+) T cells modulates interferon gamma responses via generation of adenosine (Q36341390) (← links)
- Purinergic signaling in scarring (Q36385326) (← links)
- Reversible inhibition of Chlamydia trachomatis infection in epithelial cells due to stimulation of P2X(4) receptors. (Q36396747) (← links)
- Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. (Q36422761) (← links)
- The roles of purinergic signaling during gastrointestinal inflammation (Q36448977) (← links)
- Overexpression of CD39 and high tumoral CD39⁺/CD8⁺ ratio are associated with adverse prognosis in resectable gastric cancer (Q36464610) (← links)
- CD39/NTPDase-1 activity and expression in normal leukocytes (Q36479951) (← links)
- Identification of Serum Biomarkers for Gastric Cancer Diagnosis Using a Human Proteome Microarray (Q36539497) (← links)
- CD73 is a phenotypic marker of effector memory Th17 cells in inflammatory bowel disease (Q36566752) (← links)
- CD39 Expression on T Lymphocytes Correlates With Severity of Disease in Patients With Chronic Lymphocytic Leukemia (Q36664487) (← links)
- Deletion of cd39/entpd1 results in hepatic insulin resistance (Q36842553) (← links)
- CD39 and CD73 in immunity and inflammation (Q36906658) (← links)
- Pulmonary natural killer T cells play an essential role in mediating hyperoxic acute lung injury (Q36999844) (← links)
- Rolofylline, an adenosine A1 receptor antagonist, inhibits osteoclast differentiation as an inverse agonist (Q37337859) (← links)
- CD39 expression by hepatic myeloid dendritic cells attenuates inflammation in liver transplant ischemia-reperfusion injury in mice (Q37351218) (← links)
- From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease (Q37377260) (← links)
- IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients (Q37410551) (← links)